EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology

N Thakare, F Tanase, K Saeb-Parsy, N Atassi, R Endriss, G Kamphuis, D Pérez-Fentes, M Hasan, M Brehmer, P Osther, H Jung, B Turney und 8 weitere

World Journal of Urology · 2021-11 · 39 (11) · 4247-4253

DOI: 10.1007/s00345-021-03710-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal of Urology, online erschienen am 15.05.2021. Verfasst von N Thakare und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, Cambridge, CB2 0QQ, UK. niyukta.thakare@addenbro…. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Electro Medical Systems.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: PCNL requires a lithotrite to efficiently break stones, and some devices include active suction to remove the fragments. We set out to determine the efficacy and safety of the Swiss LithoClast® Trilogy, in a prospective European multicentre evaluation and compared it to published stone clearance rates for Trilogy based on surface area (68.9 mm2/min) and using the 3D calculated stone volume (526.7 mm3/min). METHODS: Ten European centres participated in this prospective non-randomized study of Trilogy for PCNL. Objective measures of stone clearance rate, device malfunction, complications and stone-free rates were assessed. Each surgeon subjectively evaluated ergonomic and device effectiveness, on a 1-10 scale (10 = extremely ergonomic/effective) and compared to their usual lithotrite on a 1-10 scale (10 = extremely effective). RESULTS: One hundred and fifty seven PCNLs using Trilogy were included (53% male, 47% female; mean age 55 years, range 13-84 years). Mean stone clearance rate was 65.55 mm2/min or 945 mm3/min based on calculated 3D volume. Stone-free rate on fluoroscopy screening at the end of the procedure was 83%. Feedback for suction effectiveness was 9.0 with 9.1 for combination and 9.0 for overall effectiveness compared to lithotrite used previously. Ergonomic score was 8.1, the least satisfactory element. Complications included 13 (8.2%) Clavien-Dindo Grade II and 2 (1.3%) Grade III. Probe breakage was seen in 9 (5.7%), none required using a different lithotrite. CONCLUSIONS: We have demonstrated that Trilogy is highly effective at stone removal. From a user perspective, the device was perceived by surgeons to be highly effective overall and compared to the most commonly used previous lithotrite, with an excellent safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdolescentAdultAgedAged, 80 and overEquipment DesignFemaleHumansKidney CalculiMaleMiddle AgedNephrolithotomy, PercutaneousProspective StudiesTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

LithoClast®LithotritePCNLTechnologyTrilogyUrolithiasis

Autor:innen und Institutionen

  • Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, Cambridge, CB2 0QQ, UK. niyukta.thakare@addenbrookes.nhs.uk.
  • Department of Urology, Colentina Clinical Hospital, Șoseaua Ștefan cel Mare 19-21, Bucharest, Romania.
  • Department of Urology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, Hills Road, Cambridge, CB2 0QQ, UK.
  • Department of Urology, Sindelfingen-Boblingen Medical Center, Sindelfingen, Baden-Wurttemberg, Germany.
  • Amsterdam UMC Locatie AMC, Department of Urology, Amsterdam University Medical Center, Meibergdreef, 91105 AZ, Amsterdam, The Netherlands.
  • Department of Urology, University Hospital Complex of Santiago de Compostela, 15706, Santiago de Compostela, Spain.

Förderung

  • Electro Medical Systems

Zitieren

APA

Thakare, N., Tanase, F., Saeb-Parsy, K., Atassi, N., Endriss, R., Kamphuis, G., Pérez-Fentes, D., Hasan, M., Brehmer, M., Osther, P., Jung, H., Turney, B., Finch, W., Burgess, N., Irving, S., Dragos, L., Liatsikos, E., Knoll, T., Cauni, V., & Wiseman, O. (2021). Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology. World Journal of Urology, 39(11), 4247-4253. https://doi.org/10.1007/s00345-021-03710-9

Vancouver

Thakare N, Tanase F, Saeb-Parsy K, Atassi N, Endriss R, Kamphuis G, et al. Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology. World Journal of Urology. 2021;39(11):4247-4253. doi:10.1007/s00345-021-03710-9

BibTeX
@article{Thakare2021,
  author = {Thakare, N and Tanase, F and Saeb-Parsy, K and Atassi, N and Endriss, R and Kamphuis, G and Pérez-Fentes, D and Hasan, M and Brehmer, M and Osther, P and Jung, H and Turney, B and Finch, W and Burgess, N and Irving, S and Dragos, L and Liatsikos, E and Knoll, T and Cauni, V and Wiseman, O},
  title = {Efficacy and safety of the EMS Swiss LithoClast® Trilogy for PCNL: results of the European multicentre prospective study on behalf of European Section of UroTechnology},
  journal = {World Journal of Urology},
  year = {2021},
  volume = {39},
  number = {11},
  pages = {4247--4253},
  doi = {10.1007/s00345-021-03710-9}
}
Kostenlos starten →